SEC Form 4 · accession 0001261380-16-000086
IRIDEX CORP · IRIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald Steckel
Officer — VP, Operations
Period of report
Jun 6, 2016
Accepted (ET)
Jun 8, 2016 · 7:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2016 | M | 625 | $3.856 | A | 66,250 | D | |
| Common StockF1 | Jun 6, 2016 | S | 625 | $13.5168 | D | 65,625 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option Right to BuyF2,F3 | $3.856 | Jun 6, 2016 | M | 625 | D | Feb 1, 2013 | Dec 13, 2019 | Common Stock | 625 | 4,375 | D |
Explanation of responses
- F1The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $13.5 to $13.54 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- F2This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
- F3The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.